Ferroglobin

Quick links to important sections

Ferroglobin

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferroglobin

Property Description
Active ingredient Iron salt (Ferrous Sulfate or Fumarate)
Form Capsule (slow-release system), Oral Liquid (Syrup)
Pharmacological class Oral Iron Supplement, Antianemic Agent
Common use Nutritional support for Iron status and blood formation
Origin Manufactured Dietary Supplement (Combination Product)

What is Ferroglobin and What Type of Agent is it?

Ferroglobin is fundamentally classified as an Oral Iron Supplement and falls under the broader pharmacological group of Antianemic Agents. This preparation is generally designated as a manufactured Dietary Supplement or food supplement intended to provide the body with a source of the essential mineral Iron. The classification as an Antianemic Agent confirms its core role in supporting the biological processes required for healthy blood production. Supplementation with oral iron preparations is a recognized method for maintaining adequate iron status in at-risk populations. This supports individuals, such as menstruating women or those with restrictive diets, in maintaining necessary mineral reserves.

Composition: What Active Ingredient and Co-factors Does Ferroglobin Contain?

The core active entity is Iron, which is typically supplied via an inorganic salt such as Ferrous Sulfate or Ferrous Fumarate. Ferroglobin is distinguished as a Combination Product, often extending beyond simple iron replacement to include hematopoietic B vitamins (like Folic Acid and Vitamin B12) and other trace elements (Zinc, Copper). The inclusion of co-factors in this comprehensive nutrient blend is intended to support iron utilization. This composition is supplied in two primary dosage forms: a convenient Syrup (Oral Liquid) and a Capsule, the latter frequently utilizing a slow-release system intended to optimize absorption and improve gastrointestinal tolerance.

General Purpose: Why is Ferroglobin Important for the Body?

The central purpose of Ferroglobin is to supply the iron and nutrients required for the synthesis of hemoglobin, which is the erythrocyte protein responsible for oxygen transport throughout the body. By providing these necessary components, the product supports the entire complex process of blood formation (hematopoiesis). Iron serves as a component of multiple proteins and enzymes that are essential for oxygen delivery, metabolic energy, and cell proliferation. This confirms that iron plays a crucial, foundational role in overall bodily health and energy preservation.

Regulatory References

  1. Iron in diet: MedlinePlus Medical Encyclopedia
  2. Iron - Health Professional Fact Sheet

What side effects are possible with Ferroglobin?

Possible Side Effects and Safety Information

Official regulatory documentation for oral iron supplements, such as the salts contained in Ferroglobin, indicates that adverse events are most frequently associated with the Gastrointestinal System.


Classified Adverse Reactions and Systems

Adverse reactions commonly listed in government safety information are classified as Common and include constipation, diarrhea, stomach pain or cramps, nausea, and vomiting. A decreased appetite is also officially noted. These gastrointestinal effects are often described in regulatory notes as being temporary and may lessen as the body adjusts to the treatment.

A common, expected safety pattern is the occurrence of dark or black stools, which is a predictable observation linked to unabsorbed iron. Liquid formulations also have a documented risk of staining of the teeth or mouth tissues.

In the category of Immune System Disorders, the possibility of a serious allergic reaction (anaphylaxis) is officially documented, although this is classified as a Rare event.


Serious Safety Constraints and Contraindications

Regulatory labels carry a critical constraint concerning the risk of accidental overdose. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age, making this a critical safety constraint for the pediatric population.

Ferroglobin is contraindicated and must not be used in patients with conditions involving an excessive iron load in the body, such as Hemochromatosis or Hemosiderosis. Safety notes also document that iron may decrease the absorption of certain other prescribed medications, which constitutes a safety consideration for co-administration.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Ferroglobin (an iron salt supplement) establishes that accidental overdose is a leading cause of fatal poisoning in children under six years old. This mandatory warning dictates the necessity for caution and immediate response to all suspected ingestions.

Overdose typically presents in a phased manner. Initial documented manifestations include severe gastrointestinal effects such as vomiting (potentially containing blood—hematemesis) and abdominal pain. These symptoms may be followed by a deceptive latent phase before the onset of severe systemic toxicity.

Severity Classification Documented Outcomes
Severe / Life-Threatening Profound shock and cardiovascular collapse, seizures, coma, and delayed organ damage including hepatotoxicity (liver failure).

Required Emergency Action

In case of any suspected overdose, the official regulatory guidance mandates to call a doctor or poison control center immediately. If the victim has collapsed, had a seizure, or is struggling to breathe, immediately call emergency services. All ingestions of concern require extended hospital monitoring due to the risk of delayed progression. Management is supportive and symptomatic, with specific intervention, such as chelation therapy, being indicated for systemic toxicity.

Therapeutic Uses of Ferroglobin

What Ferroglobin Treats: Main Uses and Benefits

Ferroglobin is used as an Oral Iron Supplement and antianemic agent for managing underlying nutritional deficits and may assist in easing the systemic symptoms they cause, playing a role in supporting healthy oxygen transport. This therapy is indicated for iron-deficient states and is used to support the body's reserves while providing symptomatic relief.

The supplement is considered relevant for managing conditions presenting with systemic discomfort related to deficient iron stores, including Iron-Deficiency Anemia (IDA) and Iron Deficiency Without Anemia (IDNA). It is also applicable in situations involving recurrent loss or heightened need, such as during pregnancy or phases of chronic blood loss.

The core benefit is applied in addressing symptoms related to systemic imbalance, particularly persistent, unexplained fatigue and pervasive physical weakness. By supporting the body's capacity for oxygen delivery, it generally contributes to improving energy levels and supports physical endurance.

Quick Fact: Supports Management of Chronic Tiredness and Weakness

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Ferroglobin? (Official Eligibility)

The population eligibility for using Ferroglobin, an oral iron supplement, is strictly governed by regulatory documentation to prevent iron-related toxicity and manage risks associated with the dosage form.

Absolute Contraindications (Must Not Use):

  • Iron Overload Disorders: Individuals with conditions such as Hereditary Hemochromatosis or Hemosiderosis are prohibited from using the supplement due to the severe risk of iron accumulation and organ damage.
  • Active Gastrointestinal Disease: Patients with an active Peptic Ulcer or certain active Inflammatory Bowel Diseases are contraindicated, as oral iron may exacerbate these conditions.
  • Hypersensitivity: Known allergy to any component, including the iron salt or excipients.
  • Specific Anemias: Patients with non-iron-deficiency anemias, such as Hemolytic Anemia.

Age-Related Restrictions:

The product is generally permitted for use in adults and adolescents.

  • Children Under 6 Years: Iron-containing products pose a high risk of fatal accidental poisoning and must be kept out of reach.
  • Children Under 12 Years: Solid dosage forms (capsules or tablets) are typically not recommended due to safety concerns and appropriate dosing requirements.

Use During Pregnancy and Lactation:

Ferroglobin is permitted for use in both pregnant and lactating women to meet the officially recognized increase in iron requirements during these life stages.

What should I know about interactions with other medicines?

The official interaction profile for oral iron is dominated by pharmacokinetic absorption interference, resulting from the chelation of iron with other substances in the gastrointestinal tract. This binding reduces the systemic exposure for both the iron and the co-administered medicine, and is classified as a clinically significant interaction.

This absorption-reducing interaction is officially documented for several medicinal product categories. Specific interacting medicines include L-Thyroxine (a thyroid preparation), Quinolone antibiotics (such as Ciprofloxacin), Tetracycline antibiotics (such as Doxycycline), and Bisphosphonates (like Alendronate). Iron absorption is also reduced by co-administration with Antacids.

To address this, official product labeling mandates timing-based administration rules. For numerous interacting medicines, a mandatory separation of the doses, typically at least two hours apart, is required to maintain adequate exposure of the drugs. Co-administration with items like dairy products, tea, coffee, and certain cereals is also noted to impair iron absorption. Conversely, co-administration with Ascorbic Acid (Vitamin C) is officially documented to increase iron absorption. Furthermore, regulatory notes highlight that conditions like Achlorhydria (low stomach acid) can decrease the effectiveness of iron absorption, a documented physiological constraint.

Mechanism of Action

How Ferroglobin Works

Erythropoiesis and Heme Synthesis Support

Ferroglobin functions via a Source/Precursor Supply mechanism, delivering elemental iron directly to the circulation. The iron is transported and internalized by Erythroid Stem Cells in the bone marrow where it serves as a core structural component for Heme Synthesis. This process leads to the formation of hemoglobin, the primary oxygen-carrying protein in red blood cells.

Co-factor Mechanism and Pathway Synergy

Additionally, the formulation provides B-vitamins that act as Co-factors, enabling key enzymatic reactions necessary for red blood cell maturation. These co-factors facilitate necessary processes, including DNA synthesis and the efficient cellular division of precursor cells. This synergistic action facilitates coordinated activity within the entire blood formation pathway.

Physiological Consequence of Enhanced Oxygen Transport

The resulting increase in functional red blood cells and circulating hemoglobin leads to a systemic increase in the blood's capacity to transport oxygen. This physiological change influences cellular respiration throughout the body, contributing to tissue and organ metabolism.

Dosage and Administration Information

How to Use Ferroglobin: Administration Guidelines

Ferroglobin, containing oral iron salts, is administered via the oral route as either a capsule, tablet, or liquid. The regimen is structured to balance effective absorption with patient tolerance.


Dosing and Frequency Patterns

The standard adult regimen for treating established iron deficiency typically targets 100 mg to 200 mg elemental iron per day. This therapeutic range is administered either once daily or in divided doses. To enhance absorption and improve patient comfort, schedules may include an alternate-day dosing schedule.

For use during pregnancy, specific supplementation ranges (e.g., 22 mg to 27 mg elemental iron per day) are provided. Pediatric dosing is calculated based on the child's body weight or age.


Contextual and Procedural Instructions

For optimal absorption, the dose is intended to be taken on an empty stomach (one hour before or two hours after a meal). If this causes significant stomach discomfort, the dose may be taken with or just after food, though absorption may be reduced. It should not be taken with milk.

Liquid formulations must be measured accurately using the supplied dosing device, and certain solid forms (such as modified-release capsules) must be swallowed whole and must not be crushed, chewed, or sucked. The treatment duration for iron deficiency typically extends for 3 to 6 months after the condition has been corrected to ensure the replenishment of the body’s iron stores. If a dose is missed, a double dose must never be taken.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Ferroglobin


Evidence for Use in Iron-Deficiency States

Research for oral iron supplementation has been conducted through Randomized Controlled Trials (RCTs) and Systematic Reviews that examined its use for Iron-Deficiency Anemia (IDA) and Iron Deficiency Without Anemia (IDNA). These studies were generally used in research exploring how iron status changes over time in Adults diagnosed with these conditions. The outcomes observed in these trials focused on measurable shifts in hematological biomarkers, such as levels of hemoglobin and ferritin, which are objective measures tracked in research related to iron deficiency.

Studies were conducted to measure shifts in key iron status biomarkers following the introduction of oral iron preparations. Trials also reported how symptoms evolved in the observed populations, specifically monitoring patient-reported outcomes describing perceived discomfort associated with low iron reserves, such as fatigue and physical weakness. This evidence contributes to understanding symptom patterns and helps contextualize how patients reported their experience during the study period.


Research in Populations with Heightened Need or Nutritional Deficits

Studies exploring iron supplementation for conditions involving periods of heightened need rely on Authoritative Clinical Reviews and Observational Cohort Studies. Research examined cohorts such as Pregnant individuals, Menstruating women, and others with Chronic Blood Loss or Restrictive Diets. Studies monitored outcomes related to iron status, specifically tracking the maintenance of adequate iron status biomarkers.

Research highlights changes measured during the study period, with observed patterns consistent with the need for consistent supplementation in maintaining mineral status in these groups. Findings indicate that iron supplementation was observed in some studies when evaluating the prevention of deficiency in these groups.


Research Gaps and Areas of Uncertainty

What remains uncertain is the applicability of all this evidence, which is predominantly derived from studies on generic single-entity iron salts. The established evidence base, which is rated as High for addressing deficiency, primarily reflects this research. Comparative evidence is lacking for a direct assessment of this specific multi-component Dietary Supplement formulation (Ferroglobin) against simple iron salts in large RCTs. Furthermore, long-term effects on functional measures are not fully established, meaning research provides context but not individual predictions.

Key Studies & References

  1. Iron Deficiency Anemia (StatPearls - NCBI Bookshelf)
  2. Iron Supplementation (StatPearls - NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Ferroglobin (FAQ)


Q: Is Ferroglobin the same as other iron supplements I can buy?

Official product information classifies Ferroglobin as an Oral Iron Supplement that is a Combination Product. This means that in addition to the core iron salt, the formulation is designed to supply co-factors like B vitamins and trace elements. This distinguishes it from supplements that only contain a single iron component.


Q: How quickly does Ferroglobin start to show an effect?

Regulatory guidance and scientific reviews suggest that changes in perceived well-being may be observed within a few weeks of starting oral iron, though individual responses can vary. The measurable goal of treatment is to fully replenish the body's iron stores, which often requires several months of consistent use.


Q: Do I need a prescription to get Ferroglobin?

Ferroglobin is generally designated as a manufactured Dietary Supplement or food supplement in many regions. However, high-dose iron preparations are sometimes regulated as prescription medicines, so the status of the product may depend on the specific country and formulation.


Q: Can I take Ferroglobin with pain relievers like ibuprofen?

Official product labeling does not specifically list an interaction between oral iron salts and non-prescription pain relievers like ibuprofen. However, regulatory notes broadly caution that iron may interfere with the absorption of other medicines, which indicates that regulatory documents emphasize the importance of reviewing all co-administered drugs.


Q: Can people with kidney issues use Ferroglobin?

Medical reviews indicate that iron deficiency is common in people with chronic kidney disease (CKD). Regulatory reviews describe that the selection of iron therapy (oral versus intravenous) for individuals with CKD is related to factors such as the stage of kidney function and the severity of the iron deficiency.


Q: Are there any long-term effects of taking Ferroglobin?

Regulatory documents and medical reviews caution that taking high-dose iron supplements for a prolonged period, or having an undiagnosed condition where iron levels are already too high, can lead to the accumulation of iron in the body. This iron accumulation can potentially cause organ damage over time, which is why official guidelines stress the importance of monitoring.


Q: Does Ferroglobin help with low energy or tiredness?

Official claims related to the iron in this product state that it is intended to contribute to the reduction of tiredness and fatigue in individuals experiencing iron deficiency. Clinical research trials monitor changes in patient-reported fatigue as a key outcome measure.


Q: Why do some people feel dizzy after taking iron products like Ferroglobin?

Dizziness is not typically listed as an adverse reaction caused by the product itself in official safety labels. Instead, dizziness is often a documented symptom of iron deficiency or anemia, which the supplement is being used to address. This symptom may only resolve once the body's iron status has been corrected.


Q: Can Ferroglobin interfere with lab test results?

Official product labeling does not usually list interference with common blood or urine tests. However, the purpose of Ferroglobin is to intentionally change certain hematological biomarkers (blood markers) like hemoglobin and ferritin, which your doctor will track to measure the effectiveness of the therapy.


Q: Is Ferroglobin known by a different brand name?

Ferroglobin is a registered brand name for a Dietary Supplement formulation. The active ingredients—the iron salts themselves, such as Ferrous Sulfate—are widely available and marketed under numerous other trade names as both supplements and prescription medications globally.


Q: How is Ferroglobin different from a high-dose dietary supplement?

Ferroglobin is noted as a multi-component supplement, combining iron with vitamins and co-factors essential for blood formation. The composition and the use of a slow-release delivery system in the capsule form differentiate it from simple high-dose supplements, as the system is designed to optimize absorption and tolerance.


Q: Is there a maximum amount of time Ferroglobin should be used?

Official guidelines state the minimum duration for treating iron deficiency is typically 3 to 6 months after the iron status has been corrected. While no defined maximum duration is given, long-term use requires periodic monitoring of blood markers to help prevent the risk of iron overload.


Q: Why is my doctor checking my blood so often while I take Ferroglobin?

This frequent monitoring is officially conducted to measure key indicators like hemoglobin and ferritin, known as hematological biomarkers. This testing ensures that the treatment is successfully correcting the iron deficiency and is also necessary to help prevent the patient from developing an excessive iron load over time.


Q: Does Ferroglobin have a special coating or release mechanism?

Yes, the capsule form of the product is officially described as utilizing a slow-release system. This mechanism is included to release the iron gradually over time, which is intended to optimize its absorption and improve the product's tolerance in the digestive tract.


Q: Is it possible to be allergic to Ferroglobin?

Yes. Official safety documentation lists a known Hypersensitivity (allergic reaction) to any component in the product, including the active iron salt or other excipients, as an absolute contraindication for use.


Q: What happens in the body when Ferroglobin is absorbed?

Scientific and regulatory sources indicate that iron, once in the gastrointestinal tract, must be chemically reduced to the ferrous (Fe2+) state to be absorbed into the intestinal lining. From there, it is either stored within the cells or transported into the blood supply to be used in the production of hemoglobin.


Q: Is there any research on Ferroglobin for non-standard uses?

The summary of authoritative research notes that evidence is focused predominantly on core iron-deficiency states and supplementation during pregnancy. Comparative evidence and studies on long-term functional effects are noted as research gaps, and non-standard uses are not addressed in the official data.


Q: Are there differences between the way Ferroglobin is approved in the US and Europe?

The way similar iron products are regulated can differ significantly. In some regions, the product concept is classified as a Dietary Supplement (common in the US), while in other countries, comparable preparations are often regulated as full medicines (common in Europe), which results in differences in regulatory labeling and permitted claims.


Q: Why do official documents mention potential for overdose with Ferroglobin?

Official documents carry a critical warning regarding iron because accidental overdose of iron-containing products is a leading cause of fatal poisoning in young children (under six years of age). This makes safe storage a critical safety constraint for all households with children.


Q: Does my age change how I might respond to Ferroglobin?

Official information includes age-related restrictions, such as caution against using solid dosage forms in children under 12 and critical warnings against use in children under 6 due to the risk of accidental overdose. Dosing regimens are also calculated differently for pediatric and pregnant populations, reflecting differing needs and requirements.


Q: What should I do if the side effects of Ferroglobin are too bothersome?

Non-directive patient guidance suggests that if a person experiences gastrointestinal side effects like stomach upset, official administration instructions permit taking the dose with or just after food instead of on an empty stomach. This measure may reduce discomfort, though it may result in slightly reduced iron absorption.


Q: What is the definition of the condition Ferroglobin treats, in simple terms?

Ferroglobin provides the iron and nutrients needed to support blood formation. It is used to correct or prevent Iron Deficiency, a state where the body lacks enough iron to make sufficient amounts of hemoglobin, the protein in red blood cells that transports oxygen throughout the body.


Q: Can Ferroglobin interact with commonly used acid reducers?

Yes. Regulatory notes document that co-administration with products like Antacids can reduce iron absorption, as can physiological conditions like Achlorhydria (very low stomach acid). This known pharmacokinetic interference requires attention to dosing schedules.


Q: Is it true that Ferroglobin needs an acidic environment to work best?

Regulatory notes point out that the effectiveness of iron absorption may be decreased by conditions involving low stomach acid (Achlorhydria). This information supports the general understanding that an acidic environment is helpful for the initial step in the process of iron absorption.


Q: Is it necessary to take Ferroglobin at a specific time of day?

No, official instructions do not mandate a specific time of day (such as morning or evening). However, they do strictly mandate specific timing relative to food (empty stomach being preferred for optimal absorption) and relative to other medicines to avoid interactions.


Q: Does Ferroglobin contain gluten, lactose, or common allergens?

Official documentation notes that a known Hypersensitivity to any component is a contraindication. While the active ingredients are listed, specific excipients like gluten or lactose are usually detailed only in the full, regulatory-approved component list for the specific product formulation.


Q: Can Ferroglobin interact with my multivitamin?

Official guidance warns that certain other supplements, particularly those containing calcium or magnesium, can interfere with iron absorption. Official documentation highlights the importance of reviewing the composition of co-administered multivitamins to ensure they do not contain ingredients known to interfere with iron uptake.


Q: Does Ferroglobin affect how other medicines are absorbed?

Yes. Official documentation confirms that iron may decrease the absorption of certain other prescribed medications, such as specific antibiotics or thyroid preparations. This process, known as chelation, is a documented safety consideration that requires separation of dosing times.


Q: Does Ferroglobin contain any stimulant ingredients?

No. The official composition lists the active component as the mineral Iron and various hematopoietic B-vitamins as co-factors. The product's classification as an Oral Iron Supplement does not involve any ingredients classified as stimulants.

How should Ferroglobin be stored and disposed of?

How to Store and Dispose of Ferroglobin

Official regulatory guidelines establish specific requirements for the storage and disposal of this iron supplement.

Storage & Stability Requirement Official Instruction
Temperature (Unopened) Store below 25 C (or 77 F), typically at room temperature.
Protection Keep the bottle tightly closed, in a dry place, and protected from direct light. Do not freeze.
In-Use Stability (Opened) Once opened, the product must be used within a defined period (e.g., 8 weeks). Refrigeration may be required after opening to maintain stability.
Child Safety Always store the liquid out of the sight and reach of children due to the serious risk of accidental iron overdose.

Disposal of Expired or Unused Product:

Dispose of any expired or unused Ferroglobin according to local pharmaceutical take-back programs or regulations. The product should not be disposed of in household waste or wastewater systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferroglobin found in:

A-Z Index: